Clinical Trial Update: Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing vildagliptin to pioglitazone, each in combination with metformin, in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED